查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
花生過敏治療市場 - 2018-2028 年全球行業規模、佔有率、趨勢、機會和預測，按藥物類別、給藥途徑、配銷通路、地區和競爭細分
市場調查報告書
商品編碼
1331419

花生過敏治療市場 - 2018-2028 年全球行業規模、佔有率、趨勢、機會和預測，按藥物類別、給藥途徑、配銷通路、地區和競爭細分

Peanut Allergy Treatment Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Drug Class, By Route of Administration, By Distribution Channel, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 117 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球花生過敏治療市場預計在 2024-2028 年預測期內將出現令人印象深刻的成長。這種成長是由於人們對花生過敏的認知不斷提高和技術進步所致。

提高對花生過敏的認知

花生過敏日益流行正在推動全球花生過敏治療市場的成長。花生過敏已成為一個重大的公共衛生問題，影響著全世界數百萬人，並且病例數量持續上升。

因此，對花生過敏的有效治療方法的需求不斷增加。這導致了各種可以幫助管理和治療花生過敏的產品和療法的開發，例如花生過敏免疫療法、口服免疫療法和舌下免疫療法。

該市場包括花生過敏疫苗、口服免疫治療藥物、舌下免疫治療藥物等多種產品。

製藥公司和政府組織加大對研發活動的投資，開發花生過敏的有效治療方法，推動了市場的發展。此外，隨著公眾對花生過敏的認知不斷提高，預計未來幾年對花生過敏治療的需求將增加。

人們對花生過敏的認知不斷增強

對花生過敏的日益了解正在影響全球花生過敏治療市場的成長。隨著醫學研究的進步，人們對花生過敏的原因和機制有了更深入的了解，這導致了新的、更有效的治療方法的開發。

例如，研究人員現在正在探索新的免疫治療方法，可以提供更持久的花生過敏保護。此外，正在開發新的診斷工具，可以幫助醫生更準確地診斷和管理花生過敏。

隨著對花生過敏的了解不斷加深，可能會刺激對新的創新治療方法的需求。隨著越來越多的人意識到與花生過敏相關的嚴重健康風險及其對生活品質的影響，這一點尤其如此。

此外，人們對花生過敏的認知不斷提高，導致更多的資金被用於研究和開發花生過敏的新療法。這反過來又推動了全球花生過敏治療市場的成長，因為公司正在開發新產品和療法來滿足患者的需求。

對花生過敏的了解不斷加深，對全球花生過敏治療市場的成長產生了重大影響。

增加研發投資

增加研發投資是全球花生過敏治療市場成長的主要推動力。隨著花生過敏患病率持續上升，對更有效治療方法的需求不斷成長，這導致對研發活動的投資增加。

製藥公司、政府組織和研究機構正在大力投資開發針對花生過敏的創新療法。例如，正在研究新型免疫療法，包括口服和舌下免疫療法，以及新型花生過敏疫苗的開發。

這些投資還推動了更準確、更高效的花生過敏診斷工具的開發，這將幫助醫生更有效地診斷和管理病情。

此外，對研發活動的投資不斷增加，導致花生過敏治療的新方法和創新方法的發現。這包括現有藥物的新配方，以及這些藥物的新遞送機制。

可用的客製化：

根據給定的市場數據，TechSci Research 可根據公司的具體需求提供客製化服務。該報告可以使用以下自定義選項：

公司資訊

  • 其他市場參與者（最多五個）的詳細分析和概況分析。

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 考慮學習的年份
    • 主要市場細分

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要行業合作夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量和驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球花生過敏治療市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按藥物類別（抗組胺藥、腎上腺素、免疫療法、其他）
    • 按給藥途徑（口服、靜脈注射、其他）
    • 按配銷通路（零售藥房、醫院藥房、網上藥房）
    • 按地區
    • 按公司分類 (2022)
  • 產品圖
    • 按藥物類別
    • 按給藥途徑
    • 按配銷通路
    • 按地區

第 6 章：北美花生過敏治療市場前景

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按藥物類別
    • 按給藥途徑
    • 按配銷通路
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲花生過敏治療市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按藥物類別
    • 按給藥途徑
    • 按配銷通路
    • 按國家/地區
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第 8 章：亞太地區花生過敏治療市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按藥物類別
    • 按給藥途徑
    • 按配銷通路
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞

第 9 章：南美花生過敏治療市場前景

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按藥物類別
    • 按給藥途徑
    • 按配銷通路
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲花生過敏治療市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按藥物類別
    • 按給藥途徑
    • 按配銷通路
    • 按國家/地區
  • MEA：國家分析
    • 南非花生過敏治療
    • 沙烏地阿拉伯花生過敏治療
    • 阿拉伯聯合大公國花生過敏治療

第 11 章：市場動態

  • 司機
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章：全球花生過敏治療市場：SWOT 分析

第 14 章：波特的五力分析

  • 行業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第15章：競爭格局

  • 商業概覽
  • 產品供應
  • 最近的發展
  • 主要人員
  • SWOT分析
    • Vedanta Biosciences, Inc.
    • Alladapt Immunotherapeutics, Inc.
    • Regeneron Pharmaceuticals Inc.
    • Aravax Pty Ltd
    • Teva Pharmaceutical Industries Limited
    • Prota Therapeutics Pty Ltd.
    • Aimmune Therapeutics, Inc. (Nestle)
    • DBV Technologies SA
    • Sanofi SA

第 16 章：戰略建議

簡介目錄
Product Code: 15257

Global Peanut Allergy Treatment Market is expected to see impressive growth during the forecast period 2024-2028. This growth is accounted for by the increasing awareness of peanut allergy and advances in technology.

Peanut allergy is a serious and potentially life-threatening condition affecting millions of people worldwide. The Peanut Allergy Treatment Market has been growing rapidly in recent years due to the increasing prevalence of peanut allergy and the need for effective treatment options.

Advances in research have led to a better understanding of the mechanisms underlying peanut allergy, which has enabled the development of more targeted and effective treatments.

For example, the development of allergen-specific immunotherapy and gene therapies would not have been possible without advances in biotechnology and genetic engineering.

Many pharmaceutical companies and research institutions have recognized the potential of the peanut allergy treatment market and are investing heavily in developing new treatments through research and development.

Additionally, the regulatory environment is another factor driving the growth of peanut allergy treatments. Regulatory agencies such as the FDA and the European Medicines Agency (EMA) have recently issued guidelines aimed at improving the safety and efficacy of peanut allergy treatments. These guidelines have provided greater clarity for companies developing new treatments and have helped to drive innovation in the Peanut Allergy Treatment Market.

Immunotherapy, epinephrine auto-injectors, food labeling regulations, alternative foods, and gene therapy are trends that are shaping the future of peanut allergy treatment.

Immunotherapy is a treatment that aims to desensitize the patient's immune system to the allergen, in this case, peanuts. It involves introducing the allergen to the patient in gradually increasing doses over a period of several months or years, allowing the body to build up a tolerance to the allergen. Immunotherapy is a prominent form of treatment that reduces the severity of allergic reactions to peanuts.

Gene therapy is an effective treatment option that involves altering the genes responsible for producing the allergic response to peanuts. This therapy aims to eliminate the allergic response altogether, providing a potential cure for peanut allergies. While gene therapy is still in the experimental stage, it shows great promise for the future of peanut allergy treatment.

The growth of Global Peanut Allergy Treatment Market is hampered by various challenges. These challenges include the risk of severe allergic reactions, limited access to treatment, the cost of treatment, limited effectiveness, and a lack of understanding of the condition.

The last three years have seen several significant product launches related to peanut allergy treatment, providing new options for those who suffer from this condition. These products are helping to transform the peanut allergy treatment market, providing patients with new options for managing their condition and improving their quality of life. In 2020, Aimmune Therapeutics launched Palforzia, the first FDA-approved treatment for peanut allergy. Palforzia is an oral immunotherapy drug that gradually desensitizes patients to peanuts, reducing their risk of having an allergic reaction. This treatment has the potential to be life-changing for those with peanut allergy, providing a new option for managing their condition.

In 2019, DBV Technologies launched Viaskin Peanut, a peanut allergy treatment that uses a patch to deliver small amounts of peanut allergen through the skin. The treatment is designed to gradually desensitize patients to peanuts and reduce the risk of allergic reactions. Viaskin Peanut has been shown to be effective in clinical trials and has received FDA fast-track designation.

In 2019, Johnson & Johnson announced plans to launch a peanut allergy patch that delivers small amounts of peanut allergen through the skin. The patch is designed to gradually desensitize patients to peanuts and reduce the risk of allergic reactions. The peanut allergy patch is currently undergoing clinical trials and has the potential to be a game-changer in the peanut allergy treatment market.

ARA-101 is an oral immunotherapy drug developed by Aimmune Therapeutics that desensitizes patients to peanuts. ARA-101 is currently undergoing clinical trials and has shown promising results in reducing the risk of allergic reactions to peanuts. If approved, ARA-101 could be a valuable addition to the peanut allergy treatment market.

Increasing Awareness of Peanut Allergy

The increasing prevalence of peanut allergy is driving the growth of the Global Peanut Allergy Treatment Market. Peanut allergies have become a significant public health concern, affecting millions of people worldwide, and the number of cases continues to rise.

As a result, there is an increasing demand for effective treatments for peanut allergies. This has led to the development of various products and therapies that can help manage and treat peanut allergies, such as peanut allergy immunotherapy, oral immunotherapy, and sublingual immunotherapy.

The market includes various products such as peanut allergy vaccines, oral immunotherapy drugs, sublingual immunotherapy drugs, and others.

The market is being driven by increased investments in research and development activities by pharmaceutical companies and government organizations to develop effective treatments for peanut allergies. Additionally, the increasing awareness about peanut allergies among the general population is expected to boost the demand for peanut allergy treatments in the coming years.

Growing Awareness Regarding the Peanut Allergy

The growing understanding of peanut allergy is influencing the growth of the Global Peanut Allergy Treatment Market. With advances in medical research, there is a greater understanding of the causes and mechanisms of peanut allergy, which is leading to the development of new and more effective treatments.

For example, researchers are now exploring new approaches to immunotherapy that could provide longer-lasting protection against peanut allergies. Additionally, new diagnostic tools are being developed that can help physicians more accurately diagnose and manage peanut allergies.

As the understanding of peanut allergies continues to grow, it is likely to fuel demand for new and innovative treatments. This is particularly true as more people become aware of the serious health risks associated with peanut allergies and the impact they can have on quality of life.

Furthermore, the increasing awareness of peanut allergies has led to more funding being directed towards research and development of new treatments for peanut allergies. This, in turn, is driving the growth of the Global Peanut Allergy Treatment Market as companies are developing new products and therapies to meet the needs of patients.

The growing understanding of peanut allergies has a significant impact on the growth of the Global Peanut Allergy Treatment Market.

Increasing Investment in Research & Development

Increasing investment in research and development is a major driver of the growth of the Global Peanut Allergy Treatment Market. As the prevalence of peanut allergy continues to rise, there is a growing need for more effective treatments, which has led to increased investment in research and development activities.

Pharmaceutical companies, government organizations, and research institutions are investing heavily in developing new and innovative treatments for peanut allergy. For example, there is ongoing research into new types of immunotherapies, including oral and sublingual immunotherapy, as well as the development of new peanut allergy vaccines.

These investments are also driving the development of more accurate and efficient diagnostic tools for peanut allergies, which will help physicians to diagnose and manage the condition more effectively.

Moreover, the increasing investment in research and development activities has led to the discovery of new and innovative methods for peanut allergy treatment. This includes novel formulations of existing drugs, as well as new delivery mechanisms for these drugs.

Market Segmentation

Global Peanut Allergy Treatment Market can be segmented by drug class, route of administration, distribution channel, and sand region. Based on drug class, the market can be divided into antihistamines, epinephrine, immunotherapies, and others. Based on the route of administration, the market is divided into oral, intravenous, and others. Based on distribution channels, the market is divided into retail pharmacies, hospital pharmacies, and online pharmacies. Regionally, the Peanut Allergy Treatment Market can be categorized into North America, Europe, Asia Pacific, South America, and Middle East & Africa.

Market Players

Vedanta Biosciences, Inc., Alladapt Immunotherapeutics, Inc., Regeneron Pharmaceuticals Inc., Aravax Pty Ltd, Teva Pharmaceutical Industries Limited, Prota Therapeutics Pty Ltd., Aimmune Therapeutics, Inc. (Nestle), DBV Technologies SA, Sanofi SA are some of the leading players operating in the Global Peanut Allergy Treatment Market.

Report Scope:

In this report, Global Peanut Allergy Treatment Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Global Peanut Allergy Treatment Market, By Drug Class:

  • Antihistamines
  • Epinephrine
  • Immunotherapies
  • Others

Global Peanut Allergy Treatment Market, By Route of Administration:

  • Oral
  • Intravenous
  • Others

Global Peanut Allergy Treatment Market, By Distribution Channel:

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Peanut Allergy Treatment Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Peanut Allergy Treatment Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Drug Class (Antihistamines, Epinephrine, Immunotherapies, Others)
    • 5.2.2. By Route of Administration (Oral, Intravenous, Others)
    • 5.2.3. By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies)
    • 5.2.4. By Region
    • 5.2.5. By Company (2022)
  • 5.3. Product Map
    • 5.3.1. By Drug Class
    • 5.3.2. By Route of Administration
    • 5.3.3. By Distribution Channel
    • 5.3.4. By Region

6. North America Peanut Allergy Treatment Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Drug Class
    • 6.2.2. By Route of Administration
    • 6.2.3. By Distribution Channel
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Peanut Allergy Treatment Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Drug Class
        • 6.3.1.2.2. By Route of Administration
        • 6.3.1.2.3. By Distribution Channel
    • 6.3.2. Canada Peanut Allergy Treatment Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Drug Class
        • 6.3.2.2.2. By Route of Administration
        • 6.3.2.2.3. By Distribution Channel
    • 6.3.3. Mexico Peanut Allergy Treatment Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Drug Class
        • 6.3.3.2.2. By Route of Administration
        • 6.3.3.2.3. By Distribution Channel

7. Europe Peanut Allergy Treatment Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Drug Class
    • 7.2.2. By Route of Administration
    • 7.2.3. By Distribution Channel
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Peanut Allergy Treatment Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Drug Class
        • 7.3.1.2.2. By Route of Administration
        • 7.3.1.2.3. By Distribution Channel
    • 7.3.2. Germany Peanut Allergy Treatment Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Drug Class
        • 7.3.2.2.2. By Route of Administration
        • 7.3.2.2.3. By Distribution Channel
    • 7.3.3. United Kingdom Peanut Allergy Treatment Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Drug Class
        • 7.3.3.2.2. By Route of Administration
        • 7.3.3.2.3. By Distribution Channel
    • 7.3.4. Italy Peanut Allergy Treatment Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Drug Class
        • 7.3.4.2.2. By Route of Administration
        • 7.3.4.2.3. By Distribution Channel
    • 7.3.5. Spain Peanut Allergy Treatment Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Drug Class
        • 7.3.5.2.2. By Route of Administration
        • 7.3.5.2.3. By Distribution Channel

8. Asia-Pacific Peanut Allergy Treatment Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Drug Class
    • 8.2.2. By Route of Administration
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Peanut Allergy Treatment Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Drug Class
        • 8.3.1.2.2. By Route of Administration
        • 8.3.1.2.3. By Distribution Channel
    • 8.3.2. India Peanut Allergy Treatment Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Drug Class
        • 8.3.2.2.2. By Route of Administration
        • 8.3.2.2.3. By Distribution Channel
    • 8.3.3. Japan Peanut Allergy Treatment Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Drug Class
        • 8.3.3.2.2. By Route of Administration
        • 8.3.3.2.3. By Distribution Channel
    • 8.3.4. South Korea Peanut Allergy Treatment Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Drug Class
        • 8.3.4.2.2. By Route of Administration
        • 8.3.4.2.3. By Distribution Channel
    • 8.3.5. Australia Peanut Allergy Treatment Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Drug Class
        • 8.3.5.2.2. By Route of Administration
        • 8.3.5.2.3. By Distribution Channel

9. South America Peanut Allergy Treatment Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Drug Class
    • 9.2.2. By Route of Administration
    • 9.2.3. By Distribution Channel
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Peanut Allergy Treatment Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Drug Class
        • 9.3.1.2.2. By Route of Administration
        • 9.3.1.2.3. By Distribution Channel
    • 9.3.2. Argentina Peanut Allergy Treatment Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Drug Class
        • 9.3.2.2.2. By Route of Administration
        • 9.3.2.2.3. By Distribution Channel
    • 9.3.3. Colombia Peanut Allergy Treatment Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Drug Class
        • 9.3.3.2.2. By Route of Administration
        • 9.3.3.2.3. By Distribution Channel

10. Middle East and Africa Peanut Allergy Treatment Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Drug Class
    • 10.2.2. By Route of Administration
    • 10.2.3. By Distribution Channel
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Peanut Allergy Treatment Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Drug Class
        • 10.3.1.2.2. By Route of Administration
        • 10.3.1.2.3. By Distribution Channel
    • 10.3.2. Saudi Arabia Peanut Allergy Treatment Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Drug Class
        • 10.3.2.2.2. By Route of Administration
        • 10.3.2.2.3. By Distribution Channel
    • 10.3.3. UAE Peanut Allergy Treatment Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Drug Class
        • 10.3.3.2.2. By Route of Administration
        • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Peanut Allergy Treatment Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Product Offerings
  • 15.3. Recent Developments
  • 15.4. Key Personnel
  • 15.5. SWOT Analysis
    • 15.5.1. Vedanta Biosciences, Inc.
    • 15.5.2. Alladapt Immunotherapeutics, Inc.
    • 15.5.3. Regeneron Pharmaceuticals Inc.
    • 15.5.4. Aravax Pty Ltd
    • 15.5.5. Teva Pharmaceutical Industries Limited
    • 15.5.6. Prota Therapeutics Pty Ltd.
    • 15.5.7. Aimmune Therapeutics, Inc. (Nestle)
    • 15.5.8. DBV Technologies SA
    • 15.5.9. Sanofi SA

16. Strategic Recommendations